Searched for
GLENMARK LICENSED DRUG
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- Glenmark surges 20% after major drug licensing deal with AbbVieGlenmark Pharmaceuticals shares surged following a significant licensing agreement. Ichnos Glenmark Innovation partnered with AbbVie for a ...
- Glenmark bets on respiratory drug, licensing deals to improve businessGlenmark had gross debt of ₹3,765 crore as of June 30, 2022. The company over the years accumulated debt to fund its innovation-led R&D and...
- Glenmark looks to license out second drug assetGlenmark chairman and managing director Glenn Saldanha said one of the corporate objectives of the Mumbai-headquartered company is to do at...
- Glenmark to conduct Phase III trial nasal spray meant to treat Covid-19Glenmark has joined hands with the Canadian company named Sanotize. The nasal spray works by killing the virus largely in the upper airways...
- Glenmark launches biosimilar Adalimumab in IndiaGlenmark did not give any financial detail for the drug, but globally Adalimumab is estimated to be a $16 billion drug in 2016, making it t...
- Glenmark rises armed with research after five year hiatusIt may be too early to forecast how Glenmark’s drugs will fare, for the next few years, the generics business will continue to be key.
- Glenmark gets DCGI nod for phase III trials of diarrhoea drugGlenmark Pharmaceuticals today said it has received approval from Drug Controller General of India (DCGI) to conduct phase III trials for C...
- Glenmark files arbitration claim against Napo PharmaceuticalsGlenmark has filed arbitration claims against Napo Pharmaceuticals for ending a contract to develop and market diarrhea drug.
- Failures and doubting investors have not dissuaded Glenmark Pharma's Glenn SaldanhaGlenmark has netted over $200 million in milestone and upfront payments while it has spent about $120-130 million on research.
- Glenmark Pharma in $613-million licensing deal with SanofiGlenmark Pharmaceuticals has licensed a new biotech drug to France's Sanofi which has the potential to generate revenues of $613 million or...
- Glenmark settles patent suit for skin lotion with NycomedFluticasone propionate 0.05 per cent lotion by Glenmark is generic version of Nycomed's 'Cultivate' lotion.
- Glenmark Pharma: Miles to go before new drug makes a markGlenmark’s partners — US-based Napo Pharmaceuticals and Salix Pharmaceuticals — have announced completion of phase-III trials for the drug ...
- Glenmark inks licence, supply pact with TaroGlenmark Pharmaceuticals on Thursday said it has signed a licence and supply agreement with Israeli firm Taro Pharmaceuticals to sell a bra...
- Glenmark in licensing deal with US co for cholesterol drugDrug firm Glenmark on Tuesday said it has signed an exclusive licensing agreement with the US-based Par Pharmaceutical to sell generic chol...
- Glenmark inks $325-mn licensing deal with SanofiGlenmark Pharmaceuticals licensed its chronic pain molecule to Sanofi Aventis for an upfront payment of $20 million (approximately Rs 89 cr...
- Glenmark Pharma looks to out-license two molecules this yearGlenmark Pharmaceuticals on Friday said it would look at out-licensing two of its molecules this year that are in clinical trials.
- Glenmark to enter Europe with Rs 100 crore buyLeading mid-sized pharma company Glenmark Pharmaceuticals would soon enter the European market by acquiring a front-end pharmaceutical comp...
- Milestone for GlenmarkGlenmark’s out-licensing deal with the German pharma major, Merck KGaA, for its diabetes molecule, a DPP-IV inhibitor, is an important mile...
- Licensing ops galore for pharma cosIndian pharma companies that are into R&D can take heart from this bit of statistic.
Load More
